Compare Ares Capital Corporation (ARCC) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ares Capital Corporation vs 22nd Century Group Inc — how do they compare? Ares Capital Corporation trades at $19.87 (market cap $14.34B), while 22nd Century Group Inc trades at $4.38 (market cap $1.52M). The key difference: Ares Capital Corporation is far larger — about 9434.2× 22nd Century Group Inc's market cap, and Ares Capital Corporation pays a 9.61% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| ARCC | XXII | |
|---|---|---|
Market Cap | $14.34B | $1.52M |
Sector | Financials | Technology |
52-Week High | $22.68 | $801.00 |
52-Week Low | $17.45 | $3.72 |
Dividend Yield | 9.61% | — |
Enterprise Value | — | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARCC trades at $19.875, down 0.53% on the day, with strong analyst support showing 24 buy ratings and a consensus price target of $19.63. The stock maintains a bullish technical signal with moving averages supporting upward momentum, though oscillators indicate some near-term pressure. Recent earnings showed Q2 2026 EPS of $0.47, slightly below expectations, while the company continues its 17-year dividend streak with consistent $0.48 quarterly payments.
The outlook remains positive with solid fundamentals including 81.77% net income margin and 6.88% ROE, though investors should monitor declining revenue trends from $1.7B in 2024 to projected $1.2B in 2026. Key risks include private credit market strain and dividend coverage tightening to 104%, while institutional confidence remains high with no sell ratings among 32 analysts covering the stock.
XXII trades at $4.46, up 2.53% today, with a neutral technical signal and bearish moving averages. The company shows deep losses with a net income margin of -65.76% and negative ROE of -130.19%, though it beat earnings in Q3 2025. Recent news highlights VLN® retail expansion in California and New York, and a reverse stock split on June 12, 2026. Cash flow remains dependent on financing, with operating cash flow negative at -$7.72 million in 2025.
Outlook is speculative; analyst consensus is 75% buy with growth potential from VLN® market expansion, but high execution and regulatory risks persist. Investment hinges on revenue scaling to offset persistent losses, with stock volatility expected near key resistance at $5.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Read more on ARCC →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
